Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2011-07-12
2011-07-12
Kosar, Andrew D (Department: 1654)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C530S333000, C530S345000
Reexamination Certificate
active
07976863
ABSTRACT:
Biomedical devices with antimicrobial coatings are provided. One or more surfaces of the device are coated with a cationic peptide, cationic proteins, or mixtures thereof to impart antimicrobial properties to the surface.
REFERENCES:
patent: 5472703 (1995-12-01), Vanderlaan et al.
patent: 6719929 (2004-04-01), Winterton
patent: 7282214 (2007-10-01), Willcox et al.
patent: 7368127 (2008-05-01), Diana
patent: 2001/0045676 (2001-11-01), Winterton
patent: 2004/0121939 (2004-06-01), Diana
patent: 2004/0126409 (2004-07-01), Willcox
patent: 2004/0135967 (2004-07-01), Carney
patent: 2005/0008676 (2005-01-01), Qiu
patent: 0 990 924 (2000-04-01), None
patent: WO 98/40091 (1998-09-01), None
patent: WO 01/56627 (2001-08-01), None
patent: WO 02/064183 (2002-08-01), None
R. Rasul et al. Int. J. Antimicrob. Agents (2010) 35, pp. 566-572.
Subbalakshmi et al., “Biological activities of C-terminal 15-residue synthetic fragment of melittin: deign of an analog with improved antibacterial activity” FEBS Letters, 448, pp. 62-66 (1999).
Juvvadi et al., “Synthetic Melittin, Its Entantio, Retro, and Retroenantio Isomers, and Selected Chimeric Analogs: Their Antibacterial, Hemolytic, and Lipid Bilayer Action” J. Am. Chem. Soc., vol. 118, pp. 8989-8997 (1996).
Mor et al., “The Vertebrate Peptide Antibiotics Dermaseptins Have Overlapping Structural Features but Target Specific Microorganisms” J. Biol. Chem, vol. 269, pp. 31635-31641 (1994).
Aliwarga et al., “Antimicrobial peptides: a potential role in ocular therapy” Clin. Exp. Ophthalmol., vol. 29, pp. 157-160 (2001).
Boman et al., “Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids” FEBS Letters, vol. 259, pp. 103-106 (1989).
Nos-Barbera et al., “Effect of Hybrid Peptides of Cecropin A and Melittin in an Experimental Model of Bacterial Keratitis” Cornea, vol. 259, pp. 101-106 (1996).
Wold, F., Posttranslational Protein Modifications: Perspectives and Prospects, pp. 1-12 in Posttranslational Covalent Modification of Proteins, B. C. Johnson, Ed., Academic Press, New York (1983).
Seifter et al., “Analysis for Protein Modifications and Nonprotein Cofactors” (1990),Meth. Enzymol. 182, 626-646.
Rattan et al., “Protein Synthesis: Posttranslational Modifications and Aging”, (1992) Ann. N.Y. Acad. Sci. 663, 48-62.
U.S. Appl. No. 09/516,636, filed Mar. 1, 2000.
Aliwarga Yulina
Cole Nerida
Hume Emma
Wilcox Mark
Zanini Diana
Harding Karen
Johnson & Johnson Vision Care Inc.
Kosar Andrew D
LandOfFree
Biomedical devices with antimicrobial coatings does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomedical devices with antimicrobial coatings, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomedical devices with antimicrobial coatings will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2674651